Nocturnal BiPAP Therapy Improved Chronic Respiratory Failure in Chilaiditi Syndrome

夜间双水平气道正压通气疗法改善了Chilaiditi综合征患者的慢性呼吸衰竭

阅读:1

Abstract

BACKGROUND: Chilaiditi syndrome includes the Chilaiditi sign, a radiological finding where a segment of bowel loop or small intestine has wandered between the liver and diaphragm and also any symptoms related to intestinal interference. CASE PRESENTATION: We report the case of a 79-year-old man with Chilaiditi syndrome whose dyspnea and sleep disturbance improved after nocturnal biphasic positive airway pressure (BiPAP) therapy implementation. DISCUSSION: BiPAP therapy may contribute to thoracic pressure elevation and reduce diaphragmatic compression due to intestinal enlargement, thus leading to improvements in respiratory symptoms. CONCLUSION: BiPAP therapy should therefore be considered as a treatment option for Chilaiditi syndrome patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。